The US Single Use Surgical Instruments Market was valued at $790.59 Million in 2025 and projected to reach to $954.47 Million by 2030, representing a compound annual growth rate of 3.8%. The US single-use surgical instruments market is positioned for steady growth through 2030, driven by increasing surgical procedure volumes, heightened focus on infection prevention, and hospital cost management strategies favoring disposable instruments.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US single-use surgical instruments market is valued at $790.59 million in 2025 and is projected to reach $954.47 million by 2030, representing a steady CAGR of 3.8% over the forecast period.
Stringent infection control regulations and FDA compliance requirements in the US healthcare system mandate the use of sterile, single-use instruments, creating consistent demand across hospitals and surgical centers.
The US benefits from a mature healthcare infrastructure with high surgical procedure volumes, advanced operating room technologies, and widespread adoption of disposable instruments across all major surgical specialties.
While the US market grows at 3.8% CAGR, it represents a significant portion of the global market, which expands at 5.7% CAGR, indicating strong domestic demand despite slower regional growth rates.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ENDOSCOPIC INSTRUMENTS (Product Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.7% from 2025 to 2030 |
| Largest Segment | HOSPITALS & SPECIALTY CLINICS (Care Setting) |
| Market Size Base Year (Billions) | ~USD 5.91 (2025) |
| Revenue Forecast (Billions) | ~USD 7.8 (2030) |
| Segments Covered | Product Type, Type, Application, Care Setting |
4 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CARDIOVASCULAR SURGERY | 299.1 | 309.23 | 323.45 | 338.54 | 354.58 | 370.64 | 387.38 | 404.35 | 4.6 |
| ENT SURGERY | 155.64 | 161.08 | 168.64 | 176.69 | 185.24 | 193.82 | 202.77 | 211.86 | 4.7 |
| GENERAL SURGERY | 528.3 | 546.18 | 571.24 | 597.85 | 626.1 | 654.38 | 683.83 | 713.67 | 4.6 |
| GYNECOLOGY & OBSTETRICS SURGERY | 258.12 | 267.63 | 280.73 | 294.67 | 309.52 | 324.46 | 340.08 | 355.99 | 4.9 |
| OPHTHALMIC SURGERY | 103.17 | 106.44 | 111.1 | 116.04 | 121.27 | 126.5 | 131.92 | 137.41 | 4.3 |
| ORTHOPEDIC SURGERY | 366.28 | 380.46 | 399.81 | 420.42 | 442.4 | 464.6 | 487.84 | 511.59 | 5.1 |
| OTHER APPLICATIONS | 225.19 | 233.48 | 244.9 | 257.05 | 269.99 | 283.01 | 296.62 | 310.49 | 4.9 |
| TOTAL | 1935.8 | 2004.5 | 2099.86 | 2201.26 | 2309.1 | 2417.4 | 2530.43 | 2645.36 | 4.7 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| JOHNSON & JOHNSON SERVICES, INC. (ETHICON, INC.) | United States | ||
| MEDTRONIC | Ireland | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| BD | United States | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| SMITH+NEPHEW | United Kingdom | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| STRYKER | United States | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| STERIS | Ireland | Public Company | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
| PAUL HARTMANN AG | Germany | Public Company | Handheld Surgical Instrument (single-use),Electrosurgical Instrument (single-use),Endoscopic Instrument (single-use), |
| TATA SURGICAL | India | Handheld Surgical Instrument,Electrosurgical Instrument,Endoscopic Instrument, |
Johnson & Johnson Services, Inc., operating through its Ethicon subsidiary, is a United States-based medical device and surgical products company.
Medtronic is a publicly traded Irish-founded company established in 1949 with approximately 95,000 employees, operating as a global medical technology leader.
BD (Becton Dickinson) is a publicly traded United States company founded in 1897 with 72,000 employees, specializing in medical devices and diagnostic solutions.
Smith+Nephew is a publicly traded United Kingdom company founded in 1856 with 16,988 employees, specializing in medical devices and surgical products.
Stryker is a publicly traded United States company founded in 1941 with 56,000 employees, operating as a leading medical technology and surgical equipment manufacturer.
STERIS is a publicly traded company founded in Ireland in 1985, providing sterilization and contamination control solutions for healthcare and life sciences.
Paul Hartmann AG is a publicly traded German company founded in 1818 with 10,066 employees, manufacturing medical and hygiene products.
Tata Surgical is an India-based surgical products company.
The US single-use surgical instruments market is valued at $790.59 million in 2025.
The US single-use surgical instruments market is projected to reach $954.47 million by 2030.
The US market is expected to grow at a compound annual growth rate of 3.8% from 2025 to 2030.
Growth in the US is driven by stringent infection control regulations, increasing surgical volumes, patient safety priorities, and widespread adoption across hospitals and ambulatory surgical centers.
The US market prefers single-use instruments due to superior infection prevention, compliance with regulatory standards, operational efficiency, and established healthcare provider preferences for disposable devices.
The study involved significant efforts to estimate the current size of the single-use surgical instruments market. Extensive secondary research was conducted to gather information about this market. The next step was to validate these findings, assumptions, and estimates through primary research with industry experts throughout the value chain. Various methodologies were used to calculate the total market size, including top-down and bottom-up approaches. Following this, market segmentation and data triangulation procedures were employed to estimate the sizes of the different segments and subsegments within the market.
This research study extensively utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Business, Factiva, whitepapers, and company documents from public registries. The secondary research was conducted to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the single-use surgical instruments (SUSI) market. It aimed to gather crucial insights about the top players in the market, as well as to classify and segment the market according to industry trends, geographical areas, and key developments. Additionally, a database of the leading industry players was compiled using the data collected through secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Supply-side primary sources included industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, engineers, and other key executives from companies and organizations operating in the SUSI market. Demand-side primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from both corporate and government bodies.
Breakdown of Primary Interviews
Note 1: C-level executives include CEOs, COOs, and CTOs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the SUSI market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

When the market size was determined, the entire market was split into three segments. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth.
The market rankings of major players were determined using secondary data from both paid and unpaid sources. This analysis focused on their sales of SUSI. In some cases, due to data limitations, the revenue share was estimated after a detailed review of the product portfolios of large companies and their individual sales performance. Additionally, this information was verified at each stage through in-depth interviews with industry professionals.
Single-use surgical instruments are sterile medical tools designed for one-time use during procedures. Their primary purpose is to ensure safety and prevent cross-contamination. This category includes handheld instruments such as forceps, scissors, and scalpels, as well as electrosurgical instruments like cautery devices and bipolar forceps. Additionally, it encompasses endoscopic instruments, including single-use trocars and graspers, which are commonly used in minimally invasive surgeries.
Full forecast, segment splits, and company analysis for all Single Use Surgical Instruments Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report